| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/18/2006 | US7078215 HCV NS2/3 fragments and uses thereof |
| 07/18/2006 | US7078214 Aspergillus phenylalanine aminopeptidase |
| 07/18/2006 | US7078212 Mutant α-amylases |
| 07/18/2006 | US7078211 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 07/18/2006 | US7078210 DSP-3 dual-specificity phosphatase |
| 07/18/2006 | US7078207 Polypeptides having β-1,4-GalNAc transferase activity |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078205 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases |
| 07/18/2006 | US7078204 Glucose-6-phosphate dehydrogenase |
| 07/18/2006 | US7078203 Polynucleotide sequences; complementary antibodies; screening active materials capable of binding and interference with binding; genetic engineering |
| 07/18/2006 | US7078197 Peptide acceptor ligation methods |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078193 Pathogenic Escherichia coli associated protein espA |
| 07/18/2006 | US7078191 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 07/18/2006 | US7078190 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/18/2006 | US7078189 Preparing recombinant g protein coupled receptor in baculoviral/insect cell systems for generating models of receptor/ligand binding interactions; identifying modulators of membrane protein activity |
| 07/18/2006 | US7078187 Melanin concentrating hormone receptors |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078185 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
| 07/18/2006 | US7078184 Nucleotide sequences coding peptide for use in the treatment of muscle disorders |
| 07/18/2006 | US7078183 Transforming cells with genetically engineered phytic acid degrading enzyme for use in improving digestability and nutritional quality of animal feeds |
| 07/18/2006 | US7078182 TAO protein kinase polypeptides and methods of use therefor |
| 07/18/2006 | US7078179 High speed detection, isolation of cells; binding to antibodies; fluorescence classification; purification of antibody from egg yolk |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078174 Screening methods using SOCS box-containing peptides |
| 07/18/2006 | US7078171 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 07/18/2006 | US7078169 Methods for the identification of inhibitors of an isoprenoid metabolic pathway |
| 07/18/2006 | US7078166 Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| 07/18/2006 | US7078043 Malaria vaccine |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | US7078039 vaccine; inducing immunology response; peptide |
| 07/18/2006 | US7078038 Gp120 mutants and biological applications |
| 07/18/2006 | US7078036 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 07/18/2006 | US7078035 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/18/2006 | US7078032 Delivery of therapeutic biologicals from implantable tissue matrices |
| 07/18/2006 | US7078031 delivering genes; gag genes, gag protein; endothelial growth factor |
| 07/18/2006 | US7078030 Oncolytic adenovirus |
| 07/18/2006 | US7078029 Having a genome with a mutation of a TAATGARAT sequence such that, in the presence of a ICP4 gene product, a native immediate early gene is expressed from the genome with delayed kinetics |
| 07/18/2006 | US7078028 Anti-neoplastic viral agents |
| 07/18/2006 | US7078027 Human endokine alpha |
| 07/18/2006 | CA2384838C Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/18/2006 | CA2289861C A process for preparing an anti-oxidant |
| 07/18/2006 | CA2267133C Methods for labeling nucleotides, labeled nucleotides and useful intermediates |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/18/2006 | CA2194135C Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay |
| 07/18/2006 | CA2175068C The recombinant production of proteins in yeast |
| 07/13/2006 | WO2006074460A2 Method of treating food products |
| 07/13/2006 | WO2006074400A2 Method to trigger rna interference |
| 07/13/2006 | WO2006074389A2 Four-helical bundle protein zsig99 |
| 07/13/2006 | WO2006074346A2 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 07/13/2006 | WO2006074292A2 Target validation assay |
| 07/13/2006 | WO2006074216A2 Identification of molecular interactions and therapeutic uses thereof |
| 07/13/2006 | WO2006074186A2 Development and use of a new orthotopic genetically tractable non-human animal model for liver cancer |
| 07/13/2006 | WO2006074166A2 Rnai agents for maintenance of stem cells |
| 07/13/2006 | WO2006073970A2 Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
| 07/13/2006 | WO2006073892A2 Phi 15 dna polymerase |
| 07/13/2006 | WO2006073839A2 Acid fungal proteases |
| 07/13/2006 | WO2006073827A2 Neutralizing epitope-based growth enhancing vaccine |
| 07/13/2006 | WO2006073787A2 Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
| 07/13/2006 | WO2006073727A2 Recombinant dna constructs and methods for controlling gene expression |
| 07/13/2006 | WO2006073625A2 Inhibition of li expression in mammalian cells |
| 07/13/2006 | WO2006073601A2 Methods and compositions for rna interference |
| 07/13/2006 | WO2006073472A2 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 07/13/2006 | WO2006073431A2 Avipox recombinants expressing foot and mouth disease virus genes |
| 07/13/2006 | WO2006073417A2 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/13/2006 | WO2006073320A1 A ubp1 protease mutant,and its coding sequence, their applications and heterogonous protein expression system |
| 07/13/2006 | WO2006073202A1 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 07/13/2006 | WO2006073183A1 Method of judging inflammatory disease by using single nucleotdie polymorphism |
| 07/13/2006 | WO2006073133A1 Novel tannase gene and protein thereof |
| 07/13/2006 | WO2006073119A1 Polypeptide and use of the same |
| 07/13/2006 | WO2006073073A1 Stabilized ornithine transcarbamylase and immunoassay method for ornithine transcarbamylase using the same |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072801A1 Method of mutagenesis |
| 07/13/2006 | WO2006072773A1 Ribosome display or mrna display method with selection for increased stability of the protein |
| 07/13/2006 | WO2006072742A2 Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications thereof |
| 07/13/2006 | WO2006072626A1 Kir-binding agents and methods of use thereof |
| 07/13/2006 | WO2006072620A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 07/13/2006 | WO2006072603A2 Transformed plant expressing a mutansucrase and synthesizing a modified starch |
| 07/13/2006 | WO2006072601A2 THERAPEUTIC USE OF GROWTH FACTORS, NsG29 AND NsG31 |
| 07/13/2006 | WO2006072593A2 Device for magnet assisted transfer of chemical compounds into cells and method for magnet assisted transfer of proteins into cells |
| 07/13/2006 | WO2006072564A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | WO2006072563A2 Hemopexin-like structure as polypeptide-scaffold |
| 07/13/2006 | WO2006072249A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 07/13/2006 | WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof |
| 07/13/2006 | WO2006072138A1 Genetic markers for hearing loss |
| 07/13/2006 | WO2006060314A3 Generation of replication competent viruses for therapeutic use |
| 07/13/2006 | WO2006058226A9 Modified dimeric streptavidins and uses thereof |
| 07/13/2006 | WO2006050949A3 Superagonistic anti-cd28 antibody |
| 07/13/2006 | WO2006048465A3 Animal models comprising at least one mutation or one conditional ki and one conditional ko |
| 07/13/2006 | WO2006046239A3 A thymus-specific protein |
| 07/13/2006 | WO2006039717A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 07/13/2006 | WO2006039716A3 Methods of determining precise herg interactions by mutagenesis |
| 07/13/2006 | WO2006032504A3 Method for introducing genetic mutations into plant cells |
| 07/13/2006 | WO2006024509A3 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 07/13/2006 | WO2006009525A3 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 07/13/2006 | WO2006000319A3 Method for increasing pathogen-resistance in transgenic plants by expression of peroxidase |
| 07/13/2006 | WO2005117974B1 Cancer treatment method by inhibiting mage gene expression or function |
| 07/13/2006 | WO2005111211A3 Micronas and uses thereof |
| 07/13/2006 | WO2005108573A3 Method to induce rnai in prokaryotic organisms |